Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Primaxin I.M. (imipenem and cilastatin) Injectable Suspension & Primaxin I.V., Merck & Company NDA 50-587/S58 & 50-630/S21 3/4/03 3/10/03 Primaxin I.M. (imipenem and cilastatin) Injectable Suspension & Primaxin I.V., Merck & Company NDA 50-587/S53 & 50-630/S17 11/30/01 2/12/02 Primaxin I.M. (imipenem and cilastatin) Injectable Suspension, Merck & Company NDA 50-638/S015 2/4/99 7/18/01 Primaxin I.V./imipenem and cilastatin Injection Merck NDA 50-587/S048 | PRIMAXIN IM Injectable (Imipenem and Cilastatin), Merck & Co. | PRIMAXIN(tm) IV for Injection (Imipenem and Cilastatin), Merck & Co. | Primaxin I.V. Injection, Merck & Co., Labeling Revision | Primaxin I.M. Injectable Suspension, Merck & Co., Labeling Revision | Primaxin I.M. Injectable Suspension (Imipenem and Cilastatin), Merck & Co., Labeling Revision | Primaxin I.V. (Imipenem and Cilastatin) Injection, Merck & Co., Labeling Revision | Primaxin I.M. (Imipenem and Cilastatin) Injectable Suspension, Merck & Co., Labeling Revision | Primaxin I.M. (imipenem and cilastatin sodium) Injection, Merck & Co., Labeling Revision | Primaxin I.V. (imipenem and cilastatin sodium) Injection, Merck & Co., Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com